Annual Drug Patent Expirations for RUBRACA Rubraca is a drug marketed by Clovis Oncology Inc and is included in one NDA. It is available from one supplier. There are twelve…
The post New patent for Clovis Oncology drug RUBRACA appeared first on DrugPat…
Annual Drug Patent Expirations for ODOMZO Odomzo is a drug marketed by Sun Pharma Global and is included in one NDA. It is available from one supplier. There are two…
The post New patent for Sun Pharma drug ODOMZO appeared first on DrugPatentWatch – Ma…
Annual Drug Patent Expirations for ORBACTIV Orbactiv is a drug marketed by Melinta Therap and is included in one NDA. It is available from two suppliers. There are four patents…
The post New patent expiration for Melinta Therap drug ORBACTIV appeared f…
New patent expiration for Melinta Therap drug ORBACTIV Read Post »
This chart shows the drugs with the most patents in Cyprus. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Cyprus? …
Which pharmaceutical drugs have the most drug patents in Cyprus? Read Post »
This chart shows the drugs with the most patents in European Patent Office. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…
The post Which pharmaceutical drugs have the most drug patents in Euro…
Which pharmaceutical drugs have the most drug patents in European Patent Office? Read Post »
This chart shows the drugs with the most patents in European Patent Office. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…
The post Which pharmaceutical drugs have the most drug patents in Euro…
Which pharmaceutical drugs have the most drug patents in European Patent Office? Read Post »
Annual Drug Patent Expirations for TWIRLA Twirla is a drug marketed by Agile and is included in one NDA. There are eight patents protecting this drug. This drug has fifty-six…
The post New patent expiration for AGILE drug TWIRLA appeared first on DrugP…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Sweden. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical …
Which pharmaceutical companies have the most SPCs in Sweden? Read Post »
Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in two NDAs. It is available from one supplier. There are thirty-eight patents…
The post New patent for Pharmacyclics Inc drug IMBRUVICA appe…
Annual Drug Patent Expirations for COTELLIC Cotellic is a drug marketed by Genentech Inc and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent for Genentech Inc drug COTELLIC appeared first on DrugPa…
Get new actionable insights and updates from BiotechBlog
